末梢ガイドワイヤ市場：セグメント別規模、シェア、法規制、償還、インターベンション、2036年までの予測

末梢ガイドワイヤは、経皮経管血管形成術（PTA）の際に、ステントやバルーンカテーテルを末梢血管の閉塞部位に誘導するために使用されます。

人口の高齢化、先進諸国におけるこの疾患の高い有病率、および新しく改良された診断方法の開発が、血管形成術やステント留置術のような低侵襲性手技を用いた治療率の上昇に寄与しています。末梢動脈疾患（PAD）の治療に用いられる低侵襲性手技には、バルーン血管形成術、ステント留置術、アテレクトミーなどがあります。これらの治療法は回復に要する時間や感染や出血のリスクを軽減し、臨床で頻繁に用いられています。患部への到達はこれらの低侵襲的インターベンションを成功させるための主要な課題の一つであり、通常はガイドワイヤの助けを借りて克服されます。

当レポートは、世界の末梢ガイドワイヤ市場について詳細に考察し、市場における競合情勢、SWOT分析、2036年までの市場予測、地域、国別の動向などを提供しています。

目次

現在上市されている末梢ガイドワイヤと競合情勢

• 主要な業界動向の洞察
• 末梢ガイドワイヤのセグメント別総市場収益と2015年～2036年の市場展望
• セグメント別のインターベンション総数、台数、平均販売価格、市場価値に関する詳細データ

世界、地域、国別の洞察

• 末梢ガイドワイヤ市場のSWOT分析
• 末梢ガイドワイヤ市場に関する競合力学の洞察と動向
• 国別の医療制度の概要
• 国別の償還政策
• 国別の医療技術に関する規制の状況

Peripheral Guidewires Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 is built to visualize quantitative and qualitative market trends within Cardiovascular Devices therapeutic area.

Peripheral Guidewires are used during percutaneous transluminal angioplasty (PTA) for guiding stents or balloon catheters to the site of blockage in the peripheral vasculature.

The aging population, the high prevalence of the disease in the developed countries, and the development of new and improved diagnostic modalities have contributed to increased treatment rates using minimally-invasive techniques, such as angioplasty and stenting. Minimally-invasive techniques used to treat Peripheral artery disease (PAD) include balloon angioplasty, stenting, and atherectomy. These interventions have reduced recovery times and the risk of infection and bleeding, and are frequently used in clinical practice. Reaching the affected site is one of the primary challenges for success of these minimally invasive interventions and is usually overcome with the help of guidewires.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with intervention volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Peripheral Guidewires and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Peripheral Guidewires market revenue by segment and market outlooks from 2015-2036.
• Granular data on total interventions, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Intra-Peripheral Guidewires.
• Competitive dynamics insights and trends provided for Peripheral Guidewires market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Terumo Corp, Boston Scientific Corp, Abbott Laboratories, Cook Medical Inc, Medtronic Plc, Cordis Corp, Merit Medical Systems Inc, Asahi Intecc Co Ltd, Biotronik SE & Co KG, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Peripheral Guidewires marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Peripheral Guidewires market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Peripheral Guidewires market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Peripheral Guidewires market from 2015-2036.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.